Delivery Order SPE2DB22D2206-SPE2DB25FKD48
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Calquence 100 mg tablets (60-count units) on September 3, 2025, with a ceiling value of $11,187.56 and an ultimate completion date of September 24, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child contract action under...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Calquence 100 mg tablets (60-count units) under a firm fixed-price contract with a ceiling value of $22.4K. The contract, which is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, is scheduled for completion by October 17, 2025. This award was competitively procured without set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,593.77 to AmerisourceBergen Drug Corp for the supply of Calquence 100 mg tablets (60-count units) with a firm fixed price structure. This non-set-aside competitive award was announced on August 18, 2025, with an ultimate completion date of September 9, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Calquence 100 mg tablets (60 count) with a ceiling value of $5,593.77. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The order is scheduled for completion by...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Calquence 100 mg tablets (60-count units) with a ceiling value of $5,593.77. This is a firm fixed-price delivery order with an ultimate completion date of September 11, 2025, and was competitively awarded without set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,375.12 to AmerisourceBergen Drug Corp for Calquence 100 mg tablets (60-count units) on September 24, 2025, with an ultimate completion date of October 16, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitive award to the pharmaceutical distributor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Calquence 100 mg tablets (60-unit quantity) with a ceiling value of $5,593.77. This competitive award, utilizing firm fixed pricing with no set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The ultimate completion date is October 6, 2025, with performance occurring at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Calquence 100 mg tablets (60-count) valued at $5,593.77. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is due for completion by September 30, 2025, and will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of Calquence 100 mg tablets (60-count units) under a firm fixed-price contract valued at $11,187.56. The award was made on September 3, 2025, with an ultimate completion date of September 24, 2025. This non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Calquence 100 mg tablets (60-count units) valued at $11,187.56. This firm fixed-price delivery order, which is expected to be completed by August 8, 2025, represents a non-competitive award executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at the vendor's corporate office in Conshohocken,...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FKD48Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 28, 2025, for the supply of Calquence 100 mg tablets (quantity: 60 units) under a firm fixed-price contract structure. The contract ceiling value is $22,375.12, with an ultimate completion date of October 20, 2025. This non-set-aside award represents a competitively awarded delivery order executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor vehicle designated SPE2DX and extending through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has established itself as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's SPE2DX contract serves as a comprehensive global pharmaceutical support vehicle enabling supply of a broad range of pharmaceutical products and medical supplies to support Defense Health Agency operations and other government healthcare systems worldwide. This delivery order for Calquence, a specialty pharmaceutical product, exemplifies the company's role in fulfilling federal medical supply needs across multiple therapeutic domains through flexible, competitively awarded contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.4k | 9/28/25 |